› 5ew3

X-ray diffraction
2.5Å resolution

Human Vascular Endothelial Growth Factor Receptor 2 (KDR) Kinase Domain in complex with AAL993

Released:
DOI: 10.2210/pdb5ew3/pdb
PDB entry 5ew3 coloured by chain, front view.
PDB entry 5ew3 coloured by chain, side view.
PDB entry 5ew3 coloured by chain, top view.
Source organism: Homo sapiens
Primary publication:
A Novel Potent Oral Series of VEGFR2 Inhibitors Abrogate Tumor Growth by Inhibiting Angiogenesis.
Bold G, Schnell C, Furet P, McSheehy P, Brüggen J, Mestan J, Manley PW, Drückes P, Burglin M, Dürler U, Loretan J, Reuter R, Wartmann M, Theuer A, Bauer-Probst B, Martiny-Baron G, Allegrini P, Goepfert A, Wood J, Littlewood-Evans A
J Med Chem 59 132-46 (2016)
PMID: 26629594

Function and Biology Details

Reaction catalysed: 
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate
Biochemical function:
Biological process:
Cellular component:
  • not assigned
Sequence domains:

Structure analysis Details

Assembly composition:
monomeric (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-153084 (preferred)
Entry contents:
1 distinct polypeptide molecule
Macromolecule:
Vascular endothelial growth factor receptor 2 Chains: A, B
Molecule details ›
Chains: A, B
Length: 316 amino acids
Theoretical weight: 36.19 KDa
Source organism: Homo sapiens
Expression system: Spodoptera frugiperda
UniProt:
  • Canonical: P35968 (Residues: 806-1171; Coverage: 24%)
Gene names: FLK1, KDR, VEGFR2
Sequence domains: Protein tyrosine and serine/threonine kinase
Structure domains:

Ligands and Environments

1 bound ligand:
Ligand 5T2 2 x 5T2
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: SLS BEAMLINE X06SA
Spacegroup: P21
Unit cell:
a: 67.5Å b: 55.76Å c: 89.76Å
α: 90° β: 92.28° γ: 90°
R-values:
R R work R free
0.219 0.218 0.254
Expression system: Spodoptera frugiperda

Quick links

Citations

1 review citation

Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions.
Lin et al. (2016)
3 other articles

10 mentions without citation

Coupled immune stratification and identification of therapeutic candidates in patients with lung adenocarcinoma.
Hu et al. (2020)
9 more